Nonphospholipid liposome composition for sustained release...

Details Nonphospholipid liposome composition for sustained release... Nonphospholipid liposome composition for sustained release...

A - Human Necessities

61

K

167/163, 167/171

A61K 9/00 (2006.01) A61K 9/127 (2006.01) A61K 31/57 (2006.01) A61K 47/00 (2006.01)

Patent

CA 2004865

PMLF 2850.3A -82- PATENT PLTI-023 PCT ABSTRACT A novel, nonphospholipid liposome formulation for sustained release and delivery of steroids. The formulation provides prolonged release of the drug, improved therapeutic ratio, lower toxicity, reduced systemic side effects and is stable for up to three months. The formulation is suitable for sustained delivery of steroid via inhalation, parenteral, intrathecal, intraarticular, topical, ophthalmic, and oral administration and is suitable for treatment of inflammatory, arthritic, rheumatoid, topic, pulmonary and interstitial lung diseases.

Affiliated with

Also associated with

Rating

Nonphospholipid liposome composition for sustained release... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nonphospholipid liposome composition for sustained release..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonphospholipid liposome composition for sustained release... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1485844